{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:14:51Z","timestamp":1790817291787,"version":"4.1.0"},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Cardiovascular Research Center, National Research Foundation of Korea","award":["RS-2023-00276320"],"award-info":[{"award-number":["RS-2023-00276320"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Evidence for non-vitamin K antagonist oral anticoagulant (NOAC) monotherapy for older patients with atrial fibrillation (AF) and drug-eluting stents is lacking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>We aimed to evaluate the safety and efficacy of NOAC monotherapy in older AF patients with drug-eluting stents.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This is a secondary analysis of the ADAPT AF-DES randomised trial comparing NOAC monotherapy with combination therapy with NOAC plus clopidogrel in patients with AF and drug-eluting stents. Patients were stratified by age (\u226575\u00a0years and &amp;lt;75\u00a0years). Apixaban or rivaroxaban was used as the NOAC. The primary endpoint was a net adverse clinical event at 1\u00a0year after randomisation, defined as a composite of all-cause death, myocardial infarction, stent thrombosis, stroke, systemic embolism or major or clinically relevant non-major bleeding defined by the International Society on Thrombosis and Haemostasis criteria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 960 patients included in the ADAPT AF-DES trial, 376 (39.2%) patients were aged \u226575\u00a0years. In patients aged \u226575\u00a0years, the incidence of the primary endpoint was lower in the NOAC monotherapy group (9.8% vs. 22.3%; adjusted hazard ratio, 0.37; 95% confidence interval, 0.21\u20130.66; P\u2009&amp;lt;\u2009.001) than in the combination therapy group. In contrast, the incidences did not differ between treatment strategies in patients aged &amp;lt;75\u00a0years. The interaction between age groups and strategy groups did not reach statistical significance (P for interaction\u2009=\u2009.095). The reduction in major or clinically relevant non-major bleeding with NOAC monotherapy was consistent across age groups. In contrast, the benefit of NOAC monotherapy in major adverse cardiac and cerebrovascular events was more pronounced in patients aged \u226575\u00a0years, with a statistically significant interaction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this post hoc analysis, NOAC monotherapy was associated with a lower risk of net adverse clinical events, specifically within the older age subgroup. Tailored approach regarding age and individual ischaemic risk may be needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ageing\/afag224","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T11:26:13Z","timestamp":1783941973000},"source":"Crossref","is-referenced-by-count":1,"title":["Antithrombotic strategy according to age in patients with atrial fibrillation and drug-eluting stents: a post hoc analysis of the ADAPT AF-DES randomised trial"],"prefix":"10.1093","volume":"55","author":[{"given":"Sang-Hyup","family":"Lee","sequence":"first","affiliation":[{"name":"Yonsei University College of Medicine, Division of Cardiology , Seodaemun-gu, Seoul ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo-Jin","family":"Kim","sequence":"additional","affiliation":[{"name":"Kosin University Gospel Hospital, Division of Cardiology , Busan ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ae-Young","family":"Her","sequence":"additional","affiliation":[{"name":"Kangwon National University Hospital, Division of Cardiology , Chuncheon-si, Gangwon-do ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung-Ryul","family":"Cho","sequence":"additional","affiliation":[{"name":"Kangwon National University Hospital, Division of Cardiology , Chuncheon-si, Gangwon-do ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwang-Sil","family":"Kim","sequence":"additional","affiliation":[{"name":"Inje University Sanggye Paik Hospital, Division of Cardiology , Seoul, Nowon-gu ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taek-Geun","family":"Kwon","sequence":"additional","affiliation":[{"name":"Chungbuk National University Hospital, Division of Cardiology , Cheongju-si, Chungcheongbuk-do ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Wook","family":"Lim","sequence":"additional","affiliation":[{"name":"CHA University Bundang Medical Center, Division of Cardiology , Seongnam-si, Gyeonggi-do ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8251-1522","authenticated-orcid":false,"given":"Jaemin","family":"Shim","sequence":"additional","affiliation":[{"name":"Korea University Anam Hospital, Division of Cardiology , Seoul ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2842-7500","authenticated-orcid":false,"given":"Ji-Yong","family":"Jang","sequence":"additional","affiliation":[{"name":"National Health Insurance Service Ilsan Hospital, Division of Cardiology , Goyang-si, Gyeonggi-do ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4526-6120","authenticated-orcid":false,"given":"Yong-Joon","family":"Lee","sequence":"additional","affiliation":[{"name":"Yonsei University College of Medicine, Division of Cardiology , Seodaemun-gu, Seoul ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Jun","family":"Lee","sequence":"additional","affiliation":[{"name":"Yonsei University College of Medicine, Division of Cardiology , Seodaemun-gu, Seoul ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6835-4759","authenticated-orcid":false,"given":"Hee Tae","family":"Yu","sequence":"additional","affiliation":[{"name":"Yonsei University College of Medicine, Division of Cardiology , Seodaemun-gu, Seoul ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Jin","family":"Hong","sequence":"additional","affiliation":[{"name":"Yonsei University College of Medicine, Division of Cardiology , Seodaemun-gu, Seoul ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chul-Min","family":"Ahn","sequence":"additional","affiliation":[{"name":"Yonsei University College of Medicine, Division of Cardiology , Seodaemun-gu, Seoul ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2493-066X","authenticated-orcid":false,"given":"Byeong-Keuk","family":"Kim","sequence":"additional","affiliation":[{"name":"Yonsei University College of Medicine, Division of Cardiology , Seodaemun-gu, Seoul ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7748-5788","authenticated-orcid":false,"given":"Young-Guk","family":"Ko","sequence":"additional","affiliation":[{"name":"Yonsei University College of Medicine, Division of Cardiology , Seodaemun-gu, Seoul ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghoon","family":"Choi","sequence":"additional","affiliation":[{"name":"Yonsei University College of Medicine, Division of Cardiology , Seodaemun-gu, Seoul ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2090-2031","authenticated-orcid":false,"given":"Myeong-Ki","family":"Hong","sequence":"additional","affiliation":[{"name":"Yonsei University College of Medicine, Division of Cardiology , Seodaemun-gu, Seoul ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangsoo","family":"Jang","sequence":"additional","affiliation":[{"name":"Yonsei University College of Medicine, Division of Cardiology , Seodaemun-gu, Seoul ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3256-3620","authenticated-orcid":false,"given":"Hui-Nam","family":"Pak","sequence":"additional","affiliation":[{"name":"Yonsei University College of Medicine, Division of Cardiology , Seodaemun-gu, Seoul ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2263-3274","authenticated-orcid":false,"given":"Jung-Sun","family":"Kim","sequence":"additional","affiliation":[{"name":"Yonsei University College of Medicine, Division of Cardiology , Seodaemun-gu, Seoul ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Ho","family":"Heo","sequence":"additional","affiliation":[{"name":"Kosin University Gospel Hospital, Division of Cardiology , Busan ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,3]]},"reference":[{"key":"2026080312293462900_ref1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS Guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur Heart J"},{"key":"2026080312293462900_ref2","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"2026080312293462900_ref3","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jacc.2021.09.005","article-title":"2021 ACC\/AHA\/SCAI Guideline for Coronary Artery Revascularization: executive summary: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"79","author":"Lawton","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2026080312293462900_ref4","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/cir.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"key":"2026080312293462900_ref5","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/s0140-6736(12)62177-1","article-title":"Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial","volume":"381","author":"Dewilde","year":"2013","journal-title":"Lancet"},{"key":"2026080312293462900_ref6","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afac192","article-title":"Epidemiology and impact of frailty in patients with atrial fibrillation in Europe","volume":"51","author":"Proietti","year":"2022","journal-title":"Age Ageing"},{"key":"2026080312293462900_ref7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/jcm10153370","article-title":"Prognosis of atrial fibrillation patients undergoing PCI according to anticoagulants and antiplatelet agents","author":"Yoon","year":"2021","journal-title":"J Clin Med"},{"key":"2026080312293462900_ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2512091","article-title":"Therapy for atrial fibrillation in patients with drug-eluting stents","author":"Lee","year":"2025","journal-title":"N Engl J Med"},{"key":"2026080312293462900_ref9","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ahj.2024.02.014","article-title":"Optimal antithrombotic strategy in patients with atrial fibrillation beyond 1 year after drug-eluting stent implantation: design and rationale of the randomized ADAPT AF-DES trial","volume":"271","author":"Lee","year":"2024","journal-title":"Am Heart J"},{"key":"2026080312293462900_ref10","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1056\/NEJMoa1611594","article-title":"Prevention of bleeding in patients with atrial fibrillation undergoing PCI","volume":"375","author":"Gibson","year":"2016","journal-title":"N Engl J Med"},{"key":"2026080312293462900_ref11","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"2026080312293462900_ref12","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"2026080312293462900_ref13","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"key":"2026080312293462900_ref14","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1111\/jth.13140","article-title":"Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH","volume":"13","author":"Kaatz","year":"2015","journal-title":"J Thromb Haemost"},{"key":"2026080312293462900_ref15","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1161\/circulationaha.118.036768","article-title":"Open-label randomized trial comparing oral anticoagulation with and without single antiplatelet therapy in patients with atrial fibrillation and stable coronary artery disease beyond 1 year after coronary stent implantation","volume":"139","author":"Matsumura-Nakano","year":"2019","journal-title":"Circulation"},{"key":"2026080312293462900_ref16","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1056\/NEJMoa1904143","article-title":"Antithrombotic therapy for atrial fibrillation with stable coronary disease","volume":"381","author":"Yasuda","year":"2019","journal-title":"N Engl J Med"},{"key":"2026080312293462900_ref17","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1056\/NEJMoa2407362","article-title":"Edoxaban antithrombotic therapy for atrial fibrillation and stable coronary artery disease","volume":"391","author":"Cho","year":"2024","journal-title":"N Engl J Med"},{"key":"2026080312293462900_ref18","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1001\/jamacardio.2025.2611","article-title":"Age-stratified effect of rivaroxaban monotherapy for atrial fibrillation in stable coronary artery disease: a post hoc analysis of the AFIRE randomized clinical trial","volume":"10","author":"Yamaguchi","year":"2025","journal-title":"JAMA Cardiol"}],"container-title":["Age and Ageing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ageing\/article-pdf\/55\/8\/afag224\/70470890\/afag224.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ageing\/article-pdf\/55\/8\/afag224\/70470890\/afag224.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T16:29:40Z","timestamp":1785774580000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ageing\/article\/doi\/10.1093\/ageing\/afag224\/8750272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":18,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8,3]]}},"URL":"https:\/\/doi.org\/10.1093\/ageing\/afag224","relation":{},"ISSN":["0002-0729","1468-2834"],"issn-type":[{"value":"0002-0729","type":"print"},{"value":"1468-2834","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8]]},"published":{"date-parts":[[2026,8]]},"article-number":"afag224"}}